243 related articles for article (PubMed ID: 29282035)
1. Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets.
Kaemmerer D; Schindler R; Mußbach F; Dahmen U; Altendorf-Hofmann A; Dirsch O; Sänger J; Schulz S; Lupp A
BMC Cancer; 2017 Dec; 17(1):896. PubMed ID: 29282035
[TBL] [Abstract][Full Text] [Related]
2. Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy.
Kaemmerer D; Träger T; Hoffmeister M; Sipos B; Hommann M; Sänger J; Schulz S; Lupp A
Oncotarget; 2015 Sep; 6(29):27566-79. PubMed ID: 26259237
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration].
Xie YM; Yan LN; Wei B; Guo MM; Tang CW
Ai Zheng; 2007 Jul; 26(7):688-92. PubMed ID: 17626741
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas.
Bläker M; Schmitz M; Gocht A; Burghardt S; Schulz M; Bröring DC; Pace A; Greten H; De Weerth A
J Hepatol; 2004 Jul; 41(1):112-8. PubMed ID: 15246216
[TBL] [Abstract][Full Text] [Related]
5. Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.
Somorácz A; Tátrai P; Horváth G; Kiss A; Kupcsulik P; Kovalszky I; Schaff Z
Hum Pathol; 2010 Sep; 41(9):1310-9. PubMed ID: 20471664
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptors in resected hepatocellular carcinoma: status and correlation with markers of poor prognosis.
Lequoy M; Desbois-Mouthon C; Wendum D; Gupta V; Blachon JL; Scatton O; Dumont S; Bonnemaire M; Schmidlin F; Rosmorduc O; Fartoux L
Histopathology; 2017 Feb; 70(3):492-498. PubMed ID: 27391928
[TBL] [Abstract][Full Text] [Related]
7. Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin.
Stollberg S; Kämmerer D; Neubauer E; Schulz S; Simonitsch-Klupp I; Kiesewetter B; Raderer M; Lupp A
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2239-47. PubMed ID: 27544389
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer.
Stumpf C; Kaemmerer D; Neubauer E; Sänger J; Schulz S; Lupp A
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1921-1932. PubMed ID: 30076481
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Assessment of the Expression of Biliary Transportation Proteins MRP2 and MRP3 in Hepatocellular Carcinoma and in Cholangiocarcinoma.
Cirqueira CS; Felipe-Silva AS; Wakamatsu A; Marins LV; Rocha EC; de Mello ES; Alves VAF
Pathol Oncol Res; 2019 Oct; 25(4):1363-1371. PubMed ID: 29464551
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma.
Kawahara N; Ono M; Taguchi K; Okamoto M; Shimada M; Takenaka K; Hayashi K; Mosher DF; Sugimachi K; Tsuneyoshi M; Kuwano M
Hepatology; 1998 Dec; 28(6):1512-7. PubMed ID: 9828214
[TBL] [Abstract][Full Text] [Related]
11. Stromal expression of urokinase-type plasminogen activator receptor (uPAR) is associated with invasive growth in primary liver cancer.
Akahane T; Ishii M; Ohtani H; Nagura H; Toyota T
Liver; 1998 Dec; 18(6):414-9. PubMed ID: 9869396
[TBL] [Abstract][Full Text] [Related]
12. Differential Expression of Sonic Hedgehog Protein in Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Al-Bahrani R; Nagamori S; Leng R; Petryk A; Sergi C
Pathol Oncol Res; 2015 Sep; 21(4):901-8. PubMed ID: 25740074
[TBL] [Abstract][Full Text] [Related]
13. Differential somatostatin, CXCR4 chemokine and endothelin A receptor expression in WHO grade I-IV astrocytic brain tumors.
Lange F; Kaemmerer D; Behnke-Mursch J; Brück W; Schulz S; Lupp A
J Cancer Res Clin Oncol; 2018 Jul; 144(7):1227-1237. PubMed ID: 29696364
[TBL] [Abstract][Full Text] [Related]
14. Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas.
Nakatsukasa H; Ashida K; Higashi T; Ohguchi S; Tsuboi S; Hino N; Nouso K; Urabe Y; Kinugasa N; Yoshida K; Uematsu S; Ishizaki M; Kobayashi Y; Tsuji T
Hepatology; 1996 Jul; 24(1):82-8. PubMed ID: 8707287
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma.
Hu F; Miao L; Zhao Y; Xiao YY; Xu Q
Drug Des Devel Ther; 2015; 9():3625-33. PubMed ID: 26203228
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor 1 (SSTR1) and somatostatin receptor 5 (SSTR5)expression in hepatocellular carcinoma.
Koc EU; Ozgur T; Yerci O; Gurel S
Hepatogastroenterology; 2013 Oct; 60(127):1693-7. PubMed ID: 24634938
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of HBV antigens in 338 liver cell carcinomas.
Herrmann G
Z Gastroenterol; 1999 May; 37(5):329-42. PubMed ID: 10413841
[TBL] [Abstract][Full Text] [Related]
18. Microvessel density and angiogenesis in primary hepatic malignancies: Differential expression of CD31 and VEGFR-2 in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Bösmüller H; Pfefferle V; Bittar Z; Scheble V; Horger M; Sipos B; Fend F
Pathol Res Pract; 2018 Aug; 214(8):1136-1141. PubMed ID: 29935812
[TBL] [Abstract][Full Text] [Related]
19. Tricellulin expression and its prognostic significance in primary liver carcinomas.
Somorácz A; Korompay A; Törzsök P; Patonai A; Erdélyi-Belle B; Lotz G; Schaff Z; Kiss A
Pathol Oncol Res; 2014 Oct; 20(4):755-64. PubMed ID: 24652413
[TBL] [Abstract][Full Text] [Related]
20. Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study.
Zhao Q; Yu WL; Lu XY; Dong H; Gu YJ; Sheng X; Cong WM; Wu MC
Chin J Cancer; 2016 Aug; 35(1):82. PubMed ID: 27552844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]